1. Single-fraction radiosurgery outcomes for large vestibular schwannomas in the upfront or post-surgical setting: a systematic review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines

   • Constantin Tuleasca
   • Rupesh Kotecha
   • Marc Levivier

   Review Open access 16 October 2023 Pages: 1 - 20

   

2. Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors

   • David Crompton
   • Daniel Koffler
   • Daniel M. Trifiletti

   Review 27 October 2023 Pages: 21 - 28

3. Pachymeningeal disease: a systematic review and metanalysis

   • Enrique Gutiérrez-Valencia
   • Irving Sánchez
   • David B. Shultz

   Review 10 October 2023 Pages: 29 - 39

   

4. Assessing survival outcomes and complication profiles following surgical excision and radiotherapy as interventions for skull base chordoma: a systematic review of operative margins and surgical approaches

   • Nolan J. Brown
   • Julian Gendreau
   • Michael T. Lawton

   Review 25 October 2023 Pages: 41 - 51

   

5. Focused ultrasound for brain metastases: an update on global clinical trials

   • Yi-Hsiu Chen
   • David Moore
   • Yan-Hua Su

   Review 01 November 2023 Pages: 53 - 62

6. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients

   • Eric J. Lehrer
   • Atulya A. Khosla
   • Manmeet S. Ahluwalia

   Research 27 October 2023 Pages: 63 - 77

   

7. Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy

   • Chongxian Hou
   • Shenbao Shi
   • Yiquan Ke

   Research 11 October 2023 Pages: 79 - 90

   

8. Decreased eukaryotic initiation factors expression upon temozolomide treatment—potential novel implications for eIFs in glioma therapy

   • Stefanie Krassnig
   • Stefan L. Leber
   • Johannes Haybaeck

   Research Open access 31 October 2023 Pages: 91 - 100

   

9. Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma

   • Roy Strowd
   • Benjamin Ellingson
   • Stuart Grossman

   Research 21 October 2023 Pages: 101 - 112

   

10. Telomere maintenance mechanism subtype reveals different immune activity in vestibular schwannoma

    • Ji-Yong Sung
    • Jung Woo Lee

    Research Open access 21 October 2023 Pages: 113 - 126

    

11. Improved survival outcome with not-delayed radiotherapy and immediate PD-1/PD-L1 inhibitor for non-small-cell lung cancer patients with brain metastases

    • Yaner Yu
    • Haiyan Chen
    • Qichun Wei

    Research Open access 17 October 2023 Pages: 127 - 137

    

12. COX inhibitor use during definitive radiotherapy is associated with worse hearing preservation in patients with vestibular schwannoma

    • Benjamin G. Huerter
    • Kurtis C. Johnson
    • Chi Zhang

    Research 27 October 2023 Pages: 139 - 148

    

13. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases

    • Kaixuan Bai
    • Xin Chen
    • Hui Bu

    Research Open access 28 October 2023 Pages: 149 - 160

    

14. Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors

    • Sydney T. Grob
    • Kristen R. Miller
    • Jean M. Mulcahy Levy

    Research Open access 25 October 2023 Pages: 161 - 169

15. Residual diffusion-weighted imaging hyperintense signal in primary central nervous system lymphoma can predict early recurrence

    • Shumpei Onishi
    • Fumiyuki Yamasaki
    • Nobutaka Horie

    Research 13 October 2023 Pages: 171 - 179

    

16. Identification of health-related quality of life profiles among long-term survivors of primary central nervous system tumors

    • Macy L. Stockdill
    • Tito Mendoza
    • Elizabeth Vera

    Research Open access 30 October 2023 Pages: 181 - 190

17. Glioblastomas at the white matter of temporo-parietal junction cause a poor postoperative independence level

    • Riho Nakajima
    • Masashi Kinoshita
    • Mitsutoshi Nakada

    Research 17 October 2023 Pages: 191 - 199

    

18. Long-term antiseizure medication use in patients after meningioma resection: identifying predictors for successful weaning and failures

    • Erin M. Ellis
    • Michael R. Drumm
    • Jessica W. Templer

    Research 24 October 2023 Pages: 201 - 207

19. Metformin use is associated with longer survival in glioblastoma patients with MGMT gene silencing

    • Amro H. Mohammad
    • Sukhdeep Jatana
    • Roberto J. Diaz

    Research 27 October 2023 Pages: 209 - 218

    

20. The Warburg effect in patients with brain tumors: a comprehensive analysis of clinical significance

    • Seoyoung Ma
    • Hongna Lee
    • Hee-Pyoung Park

    Research 27 October 2023 Pages: 219 - 226

    

21. Expertise in neuro-oncology: 10,000 h/10 years and opportunities for flattening the curve

    • Jason Sheehan
    • Daniel Trifiletti
    • Alfredo Quinones

    Correspondence 30 October 2023 Pages: 227 - 228